Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · IEX Real-Time Price · USD
7.09
+0.03 (0.42%)
At close: Jul 19, 2024, 4:00 PM
7.20
+0.11 (1.55%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Cabaletta Bio Market Cap
Cabaletta Bio has a market cap or net worth of $342.28 million as of July 22, 2024. Its market cap has decreased by -9.93% in one year.
Market Cap
342.28M
Enterprise Value
126.60M
1-Year Change
-9.93%
Ranking
Category
Stock Price
$7.09
Market Cap Chart
Since October 25, 2019, Cabaletta Bio's market cap has increased from $225.50M to $342.28M, an increase of 51.79%. That is a compound annual growth rate of 9.21%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 342.30M | -64.81% |
Dec 29, 2023 | 972.70M | 262.41% |
Dec 30, 2022 | 268.40M | 149.91% |
Dec 31, 2021 | 107.40M | -64.22% |
Dec 31, 2020 | 300.20M | -10.60% |
Dec 31, 2019 | 335.80M | 48.91% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sight Sciences | 383.12M |
uniQure | 375.29M |
TScan Therapeutics | 372.68M |
Lexeo Therapeutics | 369.65M |
Talkspace | 360.58M |
Xeris Biopharma Holdings | 354.35M |
AC Immune | 353.14M |
Vanda Pharmaceuticals | 352.68M |